ARCHIVES

PDX Shows 27% Response In T-Cell Lymphoma In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

June 4, 2004

FDA Approves HPV Test

April 25, 2003

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

In Brief: Tomasi To Resign As Roswell Park President; Committee To Study NIH Grant Review Issues

December 15, 1995

Cancer Mortality By County For 1950-69 Now Available From GPO; Price-$9

April 26, 1974

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012